All data are based on the daily closing price as of August 25, 2025
m

M3

2413.TSE
15.26 USD
0.11
+0.73%

Overview

Last close
15.26 usd
Market cap
10.35B usd
52 week high
15.92 usd
52 week low
7.83 usd
Target price
15.66 usd

Valuation

P/E
37.7346
Forward P/E
27.5482
Price/Sales
4.9765
Price/Book Value
4.0802
Enterprise Value
9.60B usd
EV/Revenue
4.9624
EV/EBITDA
18.1937

Key financials

Revenue TTM
2.08B usd
Gross Profit TTM
1.20B usd
EBITDA TTM
529.51M usd
Earnings per Share
0.41 usd
Dividend
0.14 usd
Total assets
3.90B usd
Net debt
-741.25M usd

About

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through the Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only website for providing information to healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists, recruitment, referrals and posting job advertisements through n3.com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. Further, M3, Inc. offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
  • Symbol
    2413.TSE
  • Exchange
    TSE
  • Isin
    JP3435750009
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Health Information Services
  • CEO
    Mr. Paul J. Rice
  • Headquarter
    Tokyo
  • Web site
    https://corporate.m3.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top